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Evaluation of recommended and extended pirlimycin therapy
strategies in four high somatic cell count
A.S. Leaflet R1918
Leo Timms, Associate Professor of Animal Science
Summary and Implications
The objective of these investigations was to evaluate
efficacy of recommended and extended therapy with
pirlimycin hydrochloride (Pirsue, Pharmacia/Upjohn Co.)
for gram positive subclinical intramammary infections in 4
high SCC herds. Cow and quarter S. aureus cure rates
ranged from 0-10, and 3-50%, respectively. Variation in
cure rates across herds was attributed to differences in initial
herd prevalence and herd management, treatment regime,
and willingness to make necessary herd management
changes. Bacterial cure rates were overestimated at 12 days
post treatment. SCC at day 12 post treatment was a better
indicator of cure than bacterial culture. This supports that
bacterial cure should be assessed at least 21-28 days post
treatment. This also supports the use of extended therapies
depending on organism involved and chronicity of infection,
and that therapy success hinges on herd management
practices and attitudes.
Materials and Methods
All four herds were in danger of milk market loss due
to elevated (chronic or recent) bulk tank SCC.  Herds 1-4
had 32, 40, 57, and 115 cows, respectively. Duplicate
aseptic quarter milk samples were taken for bacterial
analysis at 14 days prior to treatment onset, day of initial
treatment, 12 (herd 1 only) and 40 days post treatment.
Composite SCC’s  were also analyzed at these times.
Recommended therapy consisted of two intramammary
treatments with one 10-ml plastet 50 mg pirlimycin HCl 24
hrs. apart. Extended therapy was the recommend treatment
series repeated three times with 48 hrs. between treatment
series. All quarters of all cows were treated with
recommended therapy in herds 1 and 2, only gram positive
infected quarters in herd 3, and gram positive infected
quarter in herd 4 with high SCC <60 days. Gram positive
infections in herd 4 associated with high SCC >60 days
were administered extended therapy.
Results and discussion
Herd 1 had 87% of cows and 52% of quarters infected
with Staph. aureus prior to treatment. Cow and quarter cure
rates on days 12 and 40 post treatment were 25 and 33%,
and 10 and 9%, respectively (Table 1). Herd 2 had 95% of
cows and 64% of quarters infected with S. aureus. Cow and
quarter cure rates were 3 and 12%, respectively (Table 1).
SCC (Table 2)for true uninfected and S. aureus cows,
respectively, were 98,000 and 2,267,000 (day 0); 149,000
and 1,575,000 (day 12);  and 243,000 and 1,820,000 (day
40) for herd one; and 69,000 and 1,383,000 (day 0), and
115,000 and 2,505,000 (day 35) for herd two. SCC of cows
apparently cured of S. aureus on day 12 but with S. aureus
in same quarters as day 0 on day 40 was 1,297,000. This
indicates that those cows were still infected as evidenced by
a continued leucocytosis into the gland even though milk
samples were bacteriologically negative. Cow and quarter
cure rates for herd 3 (Table 3) were 7 and 21% for S. aureus
(14 cows; 19 quarters) and 71 and 63% for Strep. uberis (7
cows; 8 quarters). Cow and quarter cure rates for S. aureus
in herd 4 (Table 4) using recommended and extended
therapy were 0 and 3% (27 cows; 63 quarters) and 0 and 6%
(19 cows; 60 quarters). Cow and quarter cure rates using
extended therapy on 12 quarters of 3 recent high SCC cows
in herd 4 were 0 and 50%.
Table 1.  Chronic Staphylococcus aureus mastitis infection dynamics in two herds blitz
                treated  with  Pirlimycin HC1.
Herd 1 Herd 2
S. Aureus Day 12 Day 40 Day 35
cow cure rate 25% 10%   3%
quarter cure rate 33%   9% 12%
quarter new infection rate  -   4% 10%*
*50% of cured quarters (8/16) initially infected with coagulase negative staphylococci were reinfected with S. aureus
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Table 2. Average somatic cell counts of uninfected and S. aureus infected cows pre and post
               treatment with pirlimycin HCl.
Herd 1 Herd 2
Bacterial Status Day 0 Day 12 Day 40 Day 0 Day 35
Uninfected 98 149 243 69 115
Apparent S. aureus cured** 1,297
S. aureus 2,267 1,575 1,820 1,383 2,505
* cells/ml x 1000
** Bacteriologically negative on day 12 but S. aureus positive on days 0 and 40
Table 3. Cure rates for herd 3 ( all treated with recommended pirlimycin therapy*)
                                                      Strep. uberis**                           Staph. aureus***
     Cow cure rate                                 71%                                       7%         8%****
     Quarter cure rate                            63%                                      21%       24%****
*  Treated intramammary 2X with one 10 ml plastet 50 mg pirlimycin HCl 24 hrs. apart
** 7 cows; 8 quarters                *** 14 cows, 19 quarters
****  Cure rates for 17 quarters with SCC > 300,000 for < 60 days ( 2 chronic quarters excluded)
Table 4. Cure rates for Staph aureus(herd 4) using recommended or extended pirlimycin
                therapy*
                                               Recommended therapy**                   Extended therapy
                                                                                                        chronic***     recent**
     Cow cure rate                                   0%                                        0%                 0%
     Quarter cure rate                              3%                                        6%                50%
     Quarter new infection rate               3%
*Recommended therapy = treated intramammary 2x with one 10 ml plastet 50 mg pirlimycin
   HCl 24 hrs. apart; Extended therapy = 3 series of recommended therapies 48 hrs. apart
** Cows with SCC > 300,000 for < 60 days; (recommended-27 cows, 67 quarters, recent
     extended-3 cows,8 quarters)
*** Cows with SCC > 300,000 for > 60 days (16 cows, 48 quarters)
